Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents.
|
Br J Pharmacol
|
2010
|
1.32
|
2
|
Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.
|
Psychopharmacology (Berl)
|
2007
|
1.11
|
3
|
Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats.
|
Br J Pharmacol
|
2010
|
0.99
|
4
|
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.
|
Eur Neuropsychopharmacol
|
2009
|
0.95
|
5
|
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior.
|
Pharmacol Biochem Behav
|
2010
|
0.92
|
6
|
The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats.
|
Pharmacol Biochem Behav
|
2010
|
0.92
|
7
|
Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113.
|
Pharmacol Biochem Behav
|
2008
|
0.90
|
8
|
Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.
|
Neurogastroenterol Motil
|
2010
|
0.87
|
9
|
Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.
|
Psychopharmacology (Berl)
|
2009
|
0.86
|
10
|
Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
|
Pharmacol Biochem Behav
|
2008
|
0.86
|
11
|
Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists.
|
Pharmacol Biochem Behav
|
2010
|
0.77
|